Adriaan A. van Bodegraven

机构：Zuyderland Medisch Centrum · ORCID：0000-0003-2636-303X

发表论文 309 篇 · 总被引 7003 次 · h-index 45

代表论文

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study (2022 · Clinical Gastroenterology and Hepatology · 被引 51)
Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors (2023 · Alimentary Pharmacology & Therapeutics · 被引 33)
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry (2022 · Alimentary Pharmacology & Therapeutics · 被引 28)
Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed (2022 · Journal of Clinical Medicine · 被引 27)
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial (2023 · Journal of Crohn s and Colitis · 被引 26)
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease (2022 · Alimentary Pharmacology & Therapeutics · 被引 25)